Found 5 matching trials
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
PHASE1The primary objective of this trial is to evaluate the safety and tolerabil...
Location
City of Hope Cancer Center Phoenix
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
PHASE1This study is open to adults with advanced small cell lung cancer and other...
Location
MedStar Georgetown University Hospital
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
PHASE1An open-label, multicenter study of ZL-1310 as a single agent and in combin...
A Study of ZL-1310 in Participants With Selected Solid Tumors
PHASE1A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants Wit...
Location
University of California San Francisco/Helen Diller Family Comprehensive Cancer Center
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
PHASE3The purpose of this study is to evaluate the efficacy and safety of ZL-1310...
Location
Zai Lab Site 02050